HU0300054A3 - Tumour-specific animal proteins - Google Patents

Tumour-specific animal proteins

Info

Publication number
HU0300054A3
HU0300054A3 HU0300054A HU0300054A HU0300054A3 HU 0300054 A3 HU0300054 A3 HU 0300054A3 HU 0300054 A HU0300054 A HU 0300054A HU 0300054 A HU0300054 A HU 0300054A HU 0300054 A3 HU0300054 A3 HU 0300054A3
Authority
HU
Hungary
Prior art keywords
tumour
animal proteins
specific animal
specific
proteins
Prior art date
Application number
HU0300054A
Other versions
HU0300054A2 (en
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0004269A priority Critical patent/GB0004269D0/en
Priority to GB0009905A priority patent/GB0009905D0/en
Priority to GB0021080A priority patent/GB0021080D0/en
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Priority to PCT/EP2001/001779 priority patent/WO2001062778A2/en
Publication of HU0300054A2 publication Critical patent/HU0300054A2/en
Publication of HU0300054A3 publication Critical patent/HU0300054A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
HU0300054A 2000-02-23 2001-02-16 Tumour-specific animal proteins HU0300054A3 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0004269A GB0004269D0 (en) 2000-02-23 2000-02-23 Novel compounds
GB0009905A GB0009905D0 (en) 2000-04-20 2000-04-20 Novel compounds
GB0021080A GB0021080D0 (en) 2000-08-25 2000-08-25 Novel compounds
PCT/EP2001/001779 WO2001062778A2 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins

Publications (2)

Publication Number Publication Date
HU0300054A2 HU0300054A2 (en) 2003-05-28
HU0300054A3 true HU0300054A3 (en) 2012-09-28

Family

ID=27255552

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300054A HU0300054A3 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins

Country Status (24)

Country Link
US (5) US20030157118A1 (en)
EP (2) EP1650221B1 (en)
JP (1) JP5502253B2 (en)
KR (2) KR20090085697A (en)
CN (1) CN1254541C (en)
AT (1) AT487733T (en)
AU (3) AU5615601A (en)
BR (1) BR0108654A (en)
CA (1) CA2400842C (en)
CY (2) CY1111156T1 (en)
CZ (1) CZ303468B6 (en)
DE (1) DE60143425D1 (en)
DK (2) DK1265915T3 (en)
ES (1) ES2389445T3 (en)
HK (2) HK1093513A1 (en)
HU (1) HU0300054A3 (en)
IL (2) IL151097D0 (en)
MX (1) MXPA02008279A (en)
NO (1) NO332141B1 (en)
NZ (1) NZ520673A (en)
PL (1) PL209127B1 (en)
PT (2) PT1650221E (en)
SI (2) SI1265915T1 (en)
WO (1) WO2001062778A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1889630T3 (en) * 2000-10-18 2012-03-05 Glaxosmithkline Biolog Sa Vaccines comprising MAGE antigen coupled to protein D fragment
AT487733T (en) * 2000-02-23 2010-11-15 Glaxosmithkline Biolog Sa New connections
WO2002061085A2 (en) 2000-10-31 2002-08-08 Ryan James W Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
GB0100756D0 (en) 2001-01-11 2001-02-21 Powderject Res Ltd Needleless syringe
GB0111974D0 (en) * 2001-05-16 2001-07-04 Glaxosmithkline Biolog Sa Novel Compounds
AU2003243398A1 (en) * 2002-08-29 2004-03-19 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
CN1310033C (en) * 2004-03-23 2007-04-11 中国医学科学院肿瘤医院肿瘤研究所 Method for detecting serum protein fingerprint
KR101238795B1 (en) 2007-05-24 2013-03-07 글락소스미스클라인 바이오로지칼즈 에스.에이. Lyophilised antigen composition
KR20090017655A (en) 2006-06-02 2009-02-18 글락소스미스클라인 바이오로지칼즈 에스.에이. Method for identifying whether a patient will be responder or not to immunotherapy
GB0708758D0 (en) 2007-05-04 2007-06-13 Powderject Res Ltd Particle cassettes and process thereof
JP2012528106A (en) * 2009-05-27 2012-11-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム CASB7439 construct
GB0917457D0 (en) 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
WO2011066505A2 (en) * 2009-11-30 2011-06-03 Pathak Holdings Llc Methods and compositions for filling fleshy fruits and vegetables
PT2750683T (en) * 2011-10-03 2018-06-26 Mx Adjuvac Ab Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
US10422675B2 (en) 2017-06-09 2019-09-24 Aps Technology, Inc. System and method for monitoring mud flow in a component of drilling system

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372945A (en) 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US6024983A (en) 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE10399032I1 (en) 1987-08-28 2004-01-29 Health Research Inc Recombinant viruses.
WO1989001973A2 (en) 1987-09-02 1989-03-09 Applied Biotechnology, Inc. Recombinant pox virus for immunization against tumor-associated antigens
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biolog Expression of retrovirus gag protein eukaryotic cells
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5549910A (en) 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
ES2084698T5 (en) 1989-05-04 2005-03-01 Southern Research Institute Encapsulation procedure.
JP4041535B2 (en) 1989-08-18 2008-01-30 オックスフォード バイオメディカ(ユーケー)リミテッド Recombinant retroviruses that carry vector constructs to target cells
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
KR920007887B1 (en) 1989-08-29 1992-09-18 우찌야마 히사오 Exhaust gas cleaning device for internal combustion engine
NZ235315A (en) 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
DK0500799T3 (en) 1989-11-16 1998-09-14 Univ Duke The particle-mediated transformation of animal tissue cells
FR2658432B1 (en) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres for the controlled release of water soluble materials and method of preparation.
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
SE466259B (en) 1990-05-31 1992-01-20 Arne Forsgren Protein D - an IgD-binding protein FROM Haemophilus influenzae, and anvaendning this Foer analysis, vaccines and uppreningsaendamaal
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
JP3218637B2 (en) 1990-07-26 2001-10-15 大正製薬株式会社 Stable aqueous liposomal suspension
GB2269820B (en) 1990-08-15 1995-03-29 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
JP2958076B2 (en) 1990-08-27 1999-10-06 株式会社ビタミン研究所 Multilamellar liposomes and gene trapped multilamellar liposome preparation, as well as a process for their preparation for gene transfer
GB9022190D0 (en) 1990-10-12 1990-11-28 Perham Richard N Immunogenic material
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
DE69233013D1 (en) 1991-08-20 2003-05-22 Us Gov Nat Inst Health Adenovirus mediated gentransfer into the gastrointestinal tract
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
WO1993015763A1 (en) * 1992-02-18 1993-08-19 Smithkline Beecham Corporation Vaccinal polypeptides
DK0641192T3 (en) 1992-05-18 1998-03-02 Minnesota Mining & Mfg A device for transmucosal drug delivery
DE69327599T2 (en) 1992-06-25 2000-08-10 Smithkline Beecham Biolog Adjuvants containing vaccine composition
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
CA2153391C (en) 1993-01-11 2000-08-15 Kenneth Rock Inducing cytotoxic t lymphocyte responses
US5654186A (en) 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
FR2702160B1 (en) 1993-03-02 1995-06-02 Biovecteurs As Synthetic particulate vector and preparation process.
CA2160011A1 (en) 1993-04-06 1994-10-13 Philip D. Greenberg Chimeric cytokine receptors in lymphocytes
FR2704145B1 (en) 1993-04-21 1995-07-21 Pasteur Institut particulate and pharmaceutical composition containing the vector.
AU683073B2 (en) 1993-06-07 1997-10-30 Amgen, Inc. Hybrid receptor molecules
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
AU8116494A (en) 1993-11-12 1995-06-13 Kenichi Matsubara Gene signature
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
WO1995019799A1 (en) 1994-01-21 1995-07-27 Agracetus, Inc. Gas driven gene delivery instrument
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
DE69535036T3 (en) 1994-07-15 2011-07-07 Coley Pharmaceutical Group, Inc., Mass. Immunomodulative oligonucleotides
FR2723849B1 (en) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Method to increase the immunogenicity, the product obtained and pharmaceutical composition
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
US5580579A (en) 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
EP0955059B1 (en) 1995-04-25 2007-09-19 GlaxoSmithKline Biologicals S.A. Vaccines containing a saponin and a sterol
US5738868A (en) 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
WO1997024447A1 (en) 1996-01-02 1997-07-10 Chiron Corporation Immunostimulation mediated by gene-modified dendritic cells
IL125440A (en) * 1996-02-09 2002-02-10 Smithkline Beecham Biolog Vaccines against varicella zoster virus gene ie-63 product
US5776683A (en) 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5856462A (en) 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
US5811407A (en) 1997-02-19 1998-09-22 The University Of North Carolina At Chapel Hill System for the in vivo delivery and expression of heterologous genes in the bone marrow
US6355257B1 (en) 1997-05-08 2002-03-12 Corixa Corporation Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
GB9727262D0 (en) 1997-12-24 1998-02-25 Smithkline Beecham Biolog Vaccine
PT1659178E (en) * 1998-02-05 2010-06-28 Glaxosmithkline Biolog Sa A process for the purification or production of a mage protein
TR200002338T2 (en) 1998-02-12 2002-06-21 Immune Complex Corporation Strategically renovated hepatitis B core protein.
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
JP4510283B2 (en) * 1998-03-09 2010-07-21 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Combined vaccine composition
AU746163B2 (en) 1998-04-09 2002-04-18 Smithkline Beecham Biologicals (Sa) Adjuvant compositions
AU773204C (en) 1998-08-10 2005-05-19 Antigenics Llc Compositions of CPG and saponin adjuvants and methods thereof
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
TR200102781T2 (en) * 1999-03-11 2002-01-21 Smithkline Beecham Biologicals S. A. The novel compounds
WO2001002828A2 (en) 1999-07-07 2001-01-11 Tularik Inc. Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
WO2001057252A2 (en) 2000-02-04 2001-08-09 Aeomica, Inc. Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
US7811574B2 (en) * 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
AT487733T (en) * 2000-02-23 2010-11-15 Glaxosmithkline Biolog Sa New connections
WO2002061085A2 (en) * 2000-10-31 2002-08-08 Ryan James W Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
AU2003243398A1 (en) 2002-08-29 2004-03-19 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
JP2012528106A (en) 2009-05-27 2012-11-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム CASB7439 construct

Also Published As

Publication number Publication date
AU2001256156B2 (en) 2006-01-05
EP1265915B1 (en) 2010-11-10
US20100291121A1 (en) 2010-11-18
US20030157118A1 (en) 2003-08-21
JP2003530088A (en) 2003-10-14
EP1650221A3 (en) 2006-12-20
CY1113109T1 (en) 2016-04-13
KR20090085697A (en) 2009-08-07
US8535690B2 (en) 2013-09-17
PL209127B1 (en) 2011-07-29
IL151097A (en) 2012-05-31
EP1650221A2 (en) 2006-04-26
IL151097D0 (en) 2003-04-10
AU2006201042B2 (en) 2009-10-08
BR0108654A (en) 2003-04-29
US7803379B2 (en) 2010-09-28
CA2400842A1 (en) 2001-08-30
CN1254541C (en) 2006-05-03
PT1265915E (en) 2011-02-07
CA2400842C (en) 2013-01-15
NZ520673A (en) 2004-09-24
NO20024002D0 (en) 2002-08-22
MXPA02008279A (en) 2002-11-29
HK1052710A1 (en) 2011-05-13
CY1111156T1 (en) 2015-06-11
WO2001062778A2 (en) 2001-08-30
SI1265915T1 (en) 2011-02-28
CN1426421A (en) 2003-06-25
CZ20022874A3 (en) 2003-02-12
US8207123B2 (en) 2012-06-26
WO2001062778A3 (en) 2002-04-04
HK1093513A1 (en) 2013-03-15
DK1650221T3 (en) 2012-09-03
NO332141B1 (en) 2012-07-02
NO20024002L (en) 2002-10-22
EP1265915A2 (en) 2002-12-18
US20110052615A1 (en) 2011-03-03
HU0300054A2 (en) 2003-05-28
AT487733T (en) 2010-11-15
KR20080029007A (en) 2008-04-02
PT1650221E (en) 2012-09-05
US20060171953A1 (en) 2006-08-03
AU2006201042A1 (en) 2006-03-30
SI1650221T1 (en) 2012-09-28
AU5615601A (en) 2001-09-03
PL362698A1 (en) 2004-11-02
DK1265915T3 (en) 2011-02-14
EP1650221B1 (en) 2012-06-27
US20120244175A1 (en) 2012-09-27
JP5502253B2 (en) 2014-05-28
KR100919916B1 (en) 2009-10-07
CZ303468B6 (en) 2012-10-03
DE60143425D1 (en) 2010-12-23
ES2389445T3 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
DK1337157T3 (en) Protein hydrolysates
DK1309861T3 (en) Functional protein arrays
DE60006370D1 (en) Transponders
DE60124098D1 (en) Modoficated morbillivirus v proteins
DE60037450D1 (en) Funf-helix protein
AU6104001A (en) Motion-tracking
HU0300586A3 (en) Modified factor viii
AU2784901A (en) Ultrasonic imager
EP1113799A4 (en) Protein formulations
RU2003109746A (en) Synthetic proteins stimulating erythropoesis
AU7673701A (en) Protein injection preparations
AU9419201A (en) Solid preparations
PT1280401E (en) Extensive for animals
DK1334720T3 (en) Nateglinide-containing preparations
AU5462301A (en) Protein variants having modified immunogenicity
GB0010434D0 (en) Cat flap
AU8253501A (en) Pet device
DE60143234D1 (en) Peptide
DE60139763D1 (en) Lanzes and animals
AU6994401A (en) Protein expression profiling
AU3600501A (en) Preparations stabilized over long time
AU3279901A (en) Protein c derivatives
AU8429001A (en) Description
AU9592801A (en) Tractor
AU2963902A (en) Protein arrays

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished